Patents by Inventor Benjamin M. Collman

Benjamin M. Collman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID DOSAGE FORMS
    Publication number: 20170189402
    Abstract: The present invention features solid dosage forms comprising two or more different active ingredients. In one embodiment, the present invention features a tablet dosage form comprising a first layer and a second layer, wherein the first layer comprises (1) 200 mg lopinavir, (2) ritonavir, (3) a pharmaceutically acceptable hydrophilic polymer, (4) a pharmaceutically acceptable surfactant, and (5) no more than 0.2% by weight of one or more lubricants, and the second layer comprises another therapeutic agent.
    Type: Application
    Filed: August 24, 2016
    Publication date: July 6, 2017
    Inventors: Todd MCDERMOTT, Benjamin M. COLLMAN, Weili E. WANG, Peter T. MAYER, Albert SANTIAGO, Leana O'KEEFFE, John B. MORRIS
  • Tablet Dosage Forms
    Publication number: 20140234415
    Abstract: The present invention features tablet dosage forms comprising two or more different active ingredients. In one embodiment, a tablet dosage form of the invention comprises a first layer and a second layer, wherein the first layer comprises polymer-based solid dispersion particles having a mean particle size of no more than 200 ?m.
    Type: Application
    Filed: February 19, 2014
    Publication date: August 21, 2014
    Inventors: Todd S. McDermott, Peter T. Mayer, Benjamin M. Collman, Weili Wang, Bei Chen
  • Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
    Patent number: 8080580
    Abstract: Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).
    Type: Grant
    Filed: August 24, 2009
    Date of Patent: December 20, 2011
    Assignee: Pfizer Inc.
    Inventors: Vincent Mascitti, Benjamin M. Collman
  • DIOXA-BICYCLO[3.2.1]OCTANE-2,3,4-TRIOL DERIVATIVES
    Publication number: 20100056618
    Abstract: Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).
    Type: Application
    Filed: August 24, 2009
    Publication date: March 4, 2010
    Inventors: Vincent Mascitti, Benjamin M. Collman